Nasus Pharma Ltd (NSRX) › Operating Cash FlowNasus Pharma Ltd (NSRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2023: -$1.03M2024: -$665.0K2025: -$4.92M-$4.92M2023Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$4.92M-639.5%2024-$665.0K+35.4%2023-$1.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share